David Kelley, MD

David Kelley, MD

Endocrinology Pittsburgh, PA

Physician


Office Address

  • 3601 5th Ave
    Falk Clinic, Suite 2b
    Pittsburgh, PA 15213
    Phone: (412) 383-8700

Are you Dr. Kelley?

Claim your profile and join over 50% of U.S. physicians already on Doximity.

Claim this pageNo, this isn't me

David Kelley, MD

Endocrinology Pittsburgh, PA

Physician

31 Colleague InvitesIs this you? Register Now to see 31 messages.

Summary

  • Dr. David Kelley, MD is a board certified endocrinologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in New Jersey.

Clinical Specialties & Interests

  • Endocrinology: Diabetes

Education & Training

  • Mayo School of Graduate Medical EducationMayo School of Graduate Medical Education
  • University of MarylandUniversity of Maryland
  • Oregon Health & Science UniversityOregon Health & Science University
  • University of Maryland School of MedicineUniversity of Maryland School of Medicine

Certifications & Licensure

  • NJ State Medical LicenseNJ State Medical License2008 - 2015
  • American Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineEndocrinology & Metabolism

    Publications & Presentations

    PubMed

    Grant Support

    • Look Ahead Ancillary Study: Fat Cell Size, Muscle Lipid InfiltrationNational Center For Research Resources
      2005 - 2005
    • Look Ahead: Ancillary Study: MRI Derived Organ Tissue Mass Weight LossNational Center For Research Resources
      2005 - 2005
    • Mitochondrial Impairment In Muscle Insulin ResistanceNational Center For Research Resources
      2005 - 2005
    • PET Imaging Of Regional Variation In Insulin Sensitivity Of Fatty Tissues HumansNational Center For Research Resources
      2005 - 2005
    • Multi-Tracer PET Quantitation Of Insulin Action In MuscleNational Center For Research Resources
      2005 - 2005
    • Multi-Tracer PET Quant Skeletal Muscle Insulin Resist Type 2 Diabetes MellitusNational Center For Research Resources
      2005 - 2005
    • Contrast Enhanced US Capillary Recruit MuscleNational Center For Research Resources
      2004 - 2004
    • Look Ahead: Fat Cell Size, Muscle Lipid InfiltrationNational Center For Research Resources
      2004 - 2004
    • Mitochondrial Impairment In Muscle Insulin ResistanceNational Center For Research Resources
      2004 - 2005
    • Mitochondrial Impairment In Muscle Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases
      2004 - 2006
    • PET Quant Skeletal Muscle Insulin Resist NIDDMNational Center For Research Resources
      2004 - 2004
    • Look Ahead Study: Action For Health In DiabetesNational Center For Research Resources
      2004 - 2005
    • Multi-Tracer PET Quantitation Of Insulin In MuscleNational Center For Research Resources
      2004 - 2004
    • Look Ahead: MRI Derived Organ/Tissue Weight LossNational Center For Research Resources
      2004 - 2004
    • Look Ahead Ancillary Study: MRI Derived Organ And Tissue Mass Changes WithNational Center For Research Resources
      2004 - 2005
    • Study Of Health Outcomes Of Weight-Loss (SHOW)National Institute Of Diabetes And Digestive And Kidney Diseases
      2003 - 2005
    • Multi-Tracer PET Quantitation Of Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases
      2002 - 2004
    • Glucagon Receptor Antagonist BAY 27 9955 In NIDDMNational Center For Research Resources
      2000 - 2002
    • Skeletal Muscle Metabolism Of Fatty AcidsNational Institute Of Diabetes And Digestive And Kidney Diseases
      2000 - 2004
    • Troglitazone, Metformin, &Sulfonylurea In Insulin Stimulated GlucoseNational Center For Research Resources
      1999 - 2002
    • Effects Of Obesity On Muscle FFA UtilizationNational Center For Research Resources
      1999 - 2002
    • Troglitazone, Metformin &Sulfonylurea And Insulin Stimulated GlucoseNational Center For Research Resources
      1999 - 1999
    • Effects Of Obesity On Muscle Free Fatty Acid UtilizationNational Center For Research Resources
      1999 - 1999
    • SDZ Djn608 &Glyburideon In Basal &Postprandial Hepatic GlucoseNational Center For Research Resources
      1999 - 2002
    • Obesity/Nutrition Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases
      1999 - 2006
    • Clinical Center For Look Ahead: Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases
      1999 - 2002
    • FFA Metabolism By Skeletal Muscle In Niddm--Regulation By Short Term CaloriesNational Center For Research Resources
      1998 - 1999
    • Lipid Metabolism In Pregnancy And With PreeclampsiaNational Center For Research Resources
      1998 - 2002
    • Obesity Effects On Muscle FFA UtilizationNational Institute Of Diabetes And Digestive And Kidney Diseases
      1998 - 2001
    • Clinafloxacin Effects On Sulfonylurea Control Of Glucose In NIDDMNational Center For Research Resources
      1998 - 2000
    • Examination Of Skeletal Muscle Fat Content By Mri--Efects Of Obesity And NIDDMNational Center For Research Resources
      1998 - 2002
    • Single Dose Study In Healthy Volunteers To Determine The Effect Of ClinafloxacinNational Center For Research Resources
      1997 - 1999
    • Core--Clinical Assessment FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases
      1996 - 2002
    • Effects Of NIDDM On Glucose Transport In Skeletal MuscleNational Center For Research Resources
      1996 - 2002
    • Effects Of Visceral Obesity On Muscle FFA MetabolismNational Center For Research Resources
      1996 - 1999
    • In Vivo Assessment Of Skeletal Muscle Glucose Transport In NIDDMNational Center For Research Resources
      1996 - 1996
    • Placebo-Controlled Safety And Efficacy Study Of Pimagedine In Type II DiabetesNational Center For Research Resources
      1996 - 1996
    • Skeletal Muscle Free Fatty Acid Uptake And Oxidation In ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases
      1996 - 1996
    • Skeletal Muscle FFA Oxidation During Exercise In NIDDMNational Center For Research Resources
      1996 - 1996
    • Six-Month Double-Blind Placebo-Controlled Study Of Troglitazone In NIDDMNational Center For Research Resources
      1996 - 1997
    • Visceral Obesity Effect On Muscle FFA UtilizationNational Institute Of Diabetes And Digestive And Kidney Diseases
      1995 - 1997

    Alternate Names

    • Dr. David Kelley, Dr. David Kelley, MD, Dr. D Kelley, Dr. David E Kelley

    Physicians, view Dr. Kelley's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV

    © 2015 Doximity, Inc.HelpBlogCompanyContactPrivacyDirectory